Evotec SE (EVO) Tax Provisions (2009 - 2025)
Evotec SE (EVO) reported Tax Provisions of $19.5 million for Q4 2025, up 777.74% on a YoY basis from $2.2 million in Q4 2024, and up 13134819.37% sequentially from -$148.47 in Q3 2025.
Evotec SE (EVO) Tax Provisions (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Tax Provisions data on file, last reported at $19.5 million in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 777.74% year-over-year to $19.5 million; the trailing twelve-month figure through Dec 2025 stood at $21.7 million (up 273.14% YoY), and the FY2025 full-year result was $19.5 million, up 768.09% from the prior year.
- Tax Provisions rose to $19.5 million in Q4 2025, from -$148.47 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $24.6 million in Q4 2021 to a low of -$8366.2 in Q2 2023.
- A 5-year average of $4.8 million and a median of $5458.9 in 2021 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions slumped 207.09% in 2022 and jumped 777.74% in 2025, its largest moves.
- Tracing EVO's Tax Provisions over 5 years: stood at $24.6 million in 2021, then retreated by 9.88% to $22.1 million in 2022, then slumped by 83.8% to $3.6 million in 2023, then sank by 38.01% to $2.2 million in 2024, then surged by 777.74% to $19.5 million in 2025.
- Business Quant data shows EVO's Tax Provisions at $19.5 million in Q4 2025, -$148.47 in Q3 2025, and $2.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.50 Mn |
| Sep 30, 2025 | -148.47 |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 7,952.21 |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 9,839.77 |
| Jun 30, 2023 | -8,366.21 |
| Dec 31, 2022 | 22.13 Mn |
| Sep 30, 2022 | 3,943.36 |
| Jun 30, 2022 | -3,842.47 |
| Mar 31, 2022 | -4,272.74 |
| Dec 31, 2021 | 24.55 Mn |
| Sep 30, 2021 | 5,458.92 |
| Jun 30, 2021 | -1,251.24 |
| Mar 31, 2021 | -2,886.52 |
| Dec 31, 2020 | 23.31 Mn |
| Sep 30, 2020 | 6,981.60 |
| Dec 31, 2019 | 21.43 Mn |
| Sep 30, 2010 | -171.74 |
| Jun 30, 2010 | 12.75 |